Scientists Find Antibodies that Prevent Most HIV Strains from Infecting Human Cells

Jul 17th of 2010

Diseases HIV/AIDS Immunology FEATURED BREAKING

Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat. According to the scientists, these antibodies could be used to design improved HIV vaccines, or could be further developed to prevent or treat HIV infection. Moreover, the method used to find these antibodies could be applied to isolate therape...

FDA Approves First Diagnostic Assay to detect both HIV Antigen and Antibodies

Jun 21st of 2010

Drugs HIV/AIDS Immunology FEATURED

The U.S. Food and Drug Administration today approved the first assay to detect both antigen and antibodies to Human Immunodeficiency Virus (HIV). This assay is approved for use as an aid in the diagnosis of HIV-1/HIV-2 infection in adults including pregnant women. It is also the first assay for use as an aid in the diagnosis of HIV-1/HIV-2 infection in children as young as two years old.

FDA Announces Possible Safety Concern for HIV Drug Combination

Mar 1st of 2010

Diseases HIV/AIDS Immunology

The U.S. Food and Drug Administration today announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.

Study: HIV Vaccine Demonstrates Modest Preventive Effect

Sep 24th of 2009

Research HIV/AIDS Immunology

In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.

FDA Approves Donor Screening Test for Antibodies to HIV

Sep 18th of 2009

Diseases HIV/AIDS Immunology

The U. S. Food and Drug Administration today announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism System.

ADVERTISEMENT      |      ADVERTISE WITH US

Early HIV Antiretroviral Yields Better Clinical Outcomes

Jun 9th of 2009

Research HIV/AIDS

A clinical trial has demonstrated that HIV-infected adults in a resource-limited setting are more likely to survive if they start antiretroviral therapy (ART) before their immune systems are severely compromised.

Clinical Guidelines for HIV Opportunistic Infections Updated

Apr 16th of 2009

Diseases HIV/AIDS

The first complete update in five years of the U.S. guidelines for preventing and treating HIV-associated opportunistic infections has been released by the National Institutes of Health and the Centers for Disease Control and Prevention in cooperation with the HIV Medicine Association of the Infectious Diseases Society of America (IDSA).